shopify analytics ecommerce tracking
Chinese Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion

Breakthrough Therapy Designation further demonstrates excellent clinical profile of DZD9008 (Sunvozertinib) Read more ››
By: PR Newswire Association LLC. - 27 Jan 2022
Related companies:  Dizal Pharmaceutical Co., Ltd

Adlai Nortye Announces Global License-out Agreement with Biotime for Several Products Including PD-L1 Inhibitor (AN4005) and Anti-hTNFR2 Antibody (AN3025)

Read more ››
By: PR Newswire Association LLC. - 26 Jan 2022
Related companies:  Adlai Nortye Biopharma Co.,Ltd. | Adlai Nortye

Ascletis Announces IND Filing of Its Second FASN Inhibitor ASC60 for Advanced Solid Tumors Accepted by China NMPA

Read more ››
By: PR Newswire Association LLC. - 26 Jan 2022
Related companies:  Ascletis Pharma Inc.

RemeGen's Telitacicept Demonstrates Positive Results in Phase II Trial in Treatment of Primary Sjögren's Syndrome

Telitacicept has become the world's first pSS drug to declare Phase II results Read more ››
By: PR Newswire Association LLC. - 26 Jan 2022
Related companies:  RemeGen Co., Ltd.

Leading US Market Analysis and Research Firm Ranked AnPac Bio Globally Number One in Multi-Cancer Screening and Detection Test Volume

Read more ››
By: GlobenewsWire - 25 Jan 2022
Related companies:  Anpac Technology USA (Anpac Bio) | AnPac Bio-Medical Science Co., Ltd.

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

Read more ››
By: PR Newswire Association LLC. - 25 Jan 2022
Related companies:  Immvira Co.,Ltd.

RemeGen's Telitacicept Demonstrates Positive Results in Phase II Trial in Treatment of Primary Sjögren's Syndrome

Telitacicept has become the world's first pSS drug to declare Phase II results Read more ››
By: PR Newswire Association LLC. - 25 Jan 2022
Related companies:  RemeGen Co., Ltd.

Mustang Bio Provides an Update on its IND Application for MB-207, a Lentiviral Gene Therapy for Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) in Previously Transplanted Patients

Read more ››
By: GlobenewsWire - 24 Jan 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

Read more ››
By: GlobenewsWire - 24 Jan 2022
Related companies:  Anpac Technology USA (Anpac Bio) | AnPac Bio-Medical Science Co., Ltd.

Connect Biopharma Presents Data and Analyses from the Global Phase 2b Trial of CBP-201 at the Maui Derm Conference

Read more ››
By: GlobenewsWire - 24 Jan 2022
Related companies:  Suzhou Connect Biopharmaceuticals, Ltd. | Connect Biopharma Holdings Ltd.

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 24 Jan 2022

Kintor Pharma Announced Successful Dosing of the First Patient for Acne Vulgaris Phase II Clinical Trial of KX-826

Read more ››
By: PR Newswire Association LLC. - 24 Jan 2022
Related companies:  Suzhou Kintor Pharmaceuticals, Inc.

With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer's Research

A transformative donation from the Epstein Family Foundation will accelerate Alzheimer's research at the two universities in a push to find better treatments and a cure Read more ››
By: PR Newswire Association LLC. - 24 Jan 2022

Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

-- Approximately 80% of 180 patients with recurrent glioblastoma (rGBM) in the Phase III clinical trial are expected to be randomized and enrolled by the end of December 2022;-- Phase III clinical trial evaluates progression-free survival (PFS) and overall survival (OS) of patients with rGBM;--... Read more ››
By: PR Newswire Association LLC. - 23 Jan 2022
Related companies:  Ascletis Pharma Inc.

Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd.

Enter the Huge Blue Ocean of Synthetic Biology in Advance;Improve Product Matrix in Medical Aesthetics Field Read more ››
By: PR Newswire Association LLC. - 21 Jan 2022
Related companies:  Sihuan Pharmaceutical Holdings Group Co., Ltd.

Clover’s Final SPECTRA Phase 2/3 Clinical Trial Efficacy Data Is Published in The Lancet

Read more ››
By: GlobenewsWire - 21 Jan 2022
Related companies:  Sichuan Clover Biopharmaceuticals, Inc.

Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment

Read more ››
By: PR Newswire Association LLC. - 20 Jan 2022
Related companies:  Hinova Pharmaceuticals Inc.

GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

Read more ››
By: GlobenewsWire - 20 Jan 2022
Related companies:  GenomiCare Biotechnology

Award: Boehringer Ingelheim is Global Top Employer 2022

Read more ››
By: PR Newswire Association LLC. - 20 Jan 2022

Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D.

Read more ››
By: GlobenewsWire - 19 Jan 2022
Related companies:  Adagene (Suzhou) Limited
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Looking for companies outside of China (Mainland)?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • May 2022
    • Pharma-Biotech Product & Company Valuation with Dr. P Frei
  • June 2022
    • Digital RESI
    • Product & Company Valuation Course
See Events »
Add an Event »

Latest company news

United Health Products Provides Regulatory Update
18 May 2022 (GlobenewsWire)

Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China
18 May 2022 (PR Newswire Association LLC.)

SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China
18 May 2022 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The Chinese Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com